Naltrexone, Low-Dose Naltrexone (LDN) | Research Trials Reference | Helpful Reference Links
LDN AIIC Conference: November 7, 2014 - November 8, 2014
LDN Awareness Week: November 2, 2014 - November 8, 2014
View the 2014 LDN Conference, live online streaming: Click Here
The 2014 LDN AIIC Conference is raising awareness about a ground-breaking drug (LDN) that has proven beneficial in treating over 175 health conditions
Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and raise awareness about a ground-breaking drug that can help eradicate pain for those affected by a range of autoimmune diseases and conditions.
The LDN 2014 AIIC Conference 2014 will take place on the 7th and 8th November at the MEET in Las Vegas with a number of high profile medical experts confirmed to speak. The conference also coincides with LDN Awareness Week 2014 which runs from 2nd-8th November 2014.
Doctors around the world are now starting to realize the benefits of using LDN (Low Dose Naltrexone) to treat a range of conditions from Crohn’s and HIV to MS, ME, Lyme, arthritis, infertility and more.
LDN has traditionally been used in higher doses (50mg) to treat drug/alcohol addicts but, since the 1980s, doctors have prescribed it in lower doses (3-4.5mg), and it is currently helping over a quarter of a million people worldwide suffering from a range of autoimmune conditions.
As a result, and to raise awareness of how other people could be helped, the LDN Research Trust was set up in 2004. Since that time, the group’s popularity has grown rapidly with supporters from all over the world, including prominent physicians.
LDN works as an opiate antagonist, inhibiting natural endorphins thus forcing the body to produce more which, in turn, reduces painful symptoms and improves well-being and those using it have experienced a huge improvement in their conditions, with some disappearing altogether.
Dr Mark Mandel, one of the organizers of the conference, “LDN could be benefiting hundreds of thousands more people worldwide and it is currently under-used. That’s a fact- physicians from across the world agree. This conference and the awareness week are crucial to educate and inform the medical profession and people affected by autoimmune diseases that LDN can change lives- and it has already for a quarter of a million people all over the globe. The conference will provide vital information from professionals, reverse some people’s opinions about LDN and, hopefully, assist more people in getting help and treatment to ease suffering and pain.”
LDN2014.com
Linda Elsegood, organiser and a trustee of the LDN Research Trust, who also suffers with MS, “LDN has given me my life back and I now want to help others with autoimmune diseases to improve their lives too. LDN isn’t a miracle drug or a cure but it is an inexpensive, non-toxic drug with few side effects. It works incredibly well in so many cases and has done so since 1985.”
Contact: